In company news, Codiak BioSciences (CDAK) rose almost 1% after the biopharmaceuticals company Tuesday said it was eliminating about 37% of its current workforce, leaving 53 full-time employees on its payroll. The company, which finished the June quarter with around $41.8 million in cash and equivalents, also said it was exploring potential partnerships to help extend its cash runway.
www.nasdaq.com/articles/...08-30-2022%3A-cdakbxrxamambgxxabti
www.nasdaq.com/articles/...08-30-2022%3A-cdakbxrxamambgxxabti